Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2002
10/09/2002EP1246793A2 Substituted aminomethyl-phenyl-cyclohexane derivatives
10/09/2002EP1246791A2 Aminomethyl-phenyl-cyclohexanone derivatives
10/09/2002EP1246790A1 Substituted 1 and 2 naphthol mannich bases
10/09/2002EP1246630A1 Compositions and methods for facilitating skin growth and managing skin conditions
10/09/2002EP1246629A1 Methods of using electron active compounds for managing cancer
10/09/2002EP1246623A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof
10/09/2002EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002EP1246620A1 Substituted acylhydroxamic acids and method of reducing tnf-g(a) levels
10/09/2002EP1246619A1 Urotensin-ii receptor antagonists
10/09/2002EP1049467B1 Celecoxib compositions
10/09/2002EP0754189B1 Receptor modulating agents and methods relating thereto
10/09/2002CN1373771A Vaccine
10/09/2002CN1373760A Quinuclidine derivs. as muscarinic M3 receptors ligand and their use
10/09/2002CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002CN1373745A 3-amino-2-benzyl-1-phenyl-propane derivs.
10/09/2002CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents
10/09/2002CN1373126A Crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
10/09/2002CN1372946A Antitussive medicine 'Gaolong' and its preparing process
10/09/2002CN1092049C Composition for treating late allergic reactions and inflammation diseases, and use thereof
10/09/2002CN1092030C Method for extracting sulfur-contg. component part from galic and method for preparation of oil and fat contg. same
10/08/2002US6462094 Phenylephrine tannate and guaifenesin; oral administrationfor symptomatic relief of cough associated with respiratory tract conditions such as common cold, bronchial asthma, acute and chronic bronchitis
10/08/2002US6462067 Administering histamine or salt derivative; preventing and/or reducing oxidative cellular and tissue damage; inflammatory diseases, including rheumatoid arthritis, crohn's disease, and adult respiratory distress syndrome
10/08/2002US6462047 Containing 5- or 6-membered oxygen, nitrogen and/or sulfur heteroaryl group; angina, hypertension, respiratory distress, congestive heart failure, renal failure, atherosclerosis, inflammatory diseases, strokes, bronchitis, asthma
10/08/2002US6462045 Method of treating pulmonary hypertension
10/08/2002US6462042 Tumor necrosis factor alpha converting enzyme inhibitors; inflammatory diseases, autoimmune diseases, cancer, cardio-vascular diseases, rheumatoid arthritis, osteoarthritis, osteoporosis, neurodegeneration, alzheimer's disease, stroke
10/08/2002US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/08/2002US6462020 N-formyl-met-leu-leu-phe-phe; inhibiting release of cytokines, histamines and leukotrienes; reducing adhesion, migration and aggregation of lymphocytes, eosinophils and neutrophils; rheumatoid arthritis
10/08/2002US6461822 Therapeutic targets for agents that suppress the release of inflammatory mediators such as interleukin il-1 and il-1 beta
10/08/2002US6461642 Crystallization using supercritical or subcritical fluids
10/08/2002CA2252982C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
10/08/2002CA2182486C Cyclic neurokinin a antagonists
10/08/2002CA2145775C 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract
10/06/2002CA2378565A1 Crystal structure
10/04/2002CA2342708A1 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
10/03/2002WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002WO2002077021A2 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002WO2002077017A2 Medical uses of intercellular communication facilitating compounds
10/03/2002WO2002076995A2 2-amino-propanol derivatives
10/03/2002WO2002076986A1 Pyrazolopyrimidines as therapeutic agents
10/03/2002WO2002076979A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002WO2002076977A2 Rho-kinase inhibitors
10/03/2002WO2002076976A2 Rho-kinase inhibitors
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
10/03/2002WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
10/03/2002WO2002076948A1 Novel piperidine derivatives as modulators of chemokine receptors
10/03/2002WO2002076946A2 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
10/03/2002WO2002076945A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002WO2002076933A1 Formailide derivatives as beta2-adrenoreceptor agonists
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076480A1 Cannabis sativa extract for the treatment of migraine
10/03/2002WO2002076478A1 Bioactivity of methyl palmitate obtained from a mangrove plant salvadora persica l
10/03/2002WO2002076468A1 Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors
10/03/2002WO2002076457A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
10/03/2002WO2002076434A2 Nicotinic receptor agonists for the treatment of inflammatory diseases
10/03/2002WO2002076400A2 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
10/03/2002WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002WO2002062784A8 Piperidinee derivatives as neurokinin 1 antagonists
10/03/2002WO2002046226A3 Trefoil factor 2 (tff2) peptides with moiety attached to asn15
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002US20020143162 Methods
10/03/2002US20020143145 Detcting moduators of binding activity of preferential membrane proteins; obtain animal, incubate with modulator, monitor adjustment in activity from recptors
10/03/2002US20020143043 For therapy and prophylaxis of rheumatoid arthritis, or of allergic disorders, asthma, inflammation; inhibitors of the adhesion and migration of leucocytes and/or antagonists of adhesion receptor VLA-4 belonging to the integrins group
10/03/2002US20020143032 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020142984 Administering a positively charged liposome to animal, wherein positively charged liposome is associated with nucleic acid molecule, wherein nucleic acid molecule is in operable association with a promoter
10/03/2002US20020142956 Administering an agent which triggers anion efflux in respiratory tissue via the activation of a secretin receptor for therapy of cystic fibrosis
10/03/2002US20020142946 Cyclosporins for the treatment of respiratory diseases
10/03/2002US20020142436 Enzymatic protein for use in the treatment of tumors, nervous system, cardiovascular, psychological, pregnancy, bone, kidney, respiratory and alimentary canal disorders
10/03/2002US20020142372 Fragments of cr1 and their use
10/03/2002US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002US20020141991 Methods of treating inflammatory disease using antibodies which bind GPR-9-6
10/03/2002US20020141989 Antiinflammatory agents; antiallergens
10/03/2002US20020141988 Therapeutic agent for acute lung injury resulting from indirect causes comprising anti-il-8 antibody as active ingredient
10/03/2002US20020141972 Administering protein and antiinflection agent
10/03/2002US20020141945 Characteristic glass transition temperature (Tg) and a recommended storage temperature (Ts), glassy matrix and drug within the glassy matrix; unit dosage; stable dispersion over time
10/03/2002CA2442576A1 Bioactivity of methyl palmitate obtained from a mangrove plant salvadora persica l
10/03/2002CA2442178A1 2-amino-propanol derivatives
10/03/2002CA2441933A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
10/03/2002CA2441806A1 Inosine compounds and their use for treating or preventing an inflammation or a reperfusion disease
10/03/2002CA2441790A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002CA2441599A1 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain
10/03/2002CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002CA2440389A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002CA2439431A1 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/02/2002EP1245676A1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof
10/02/2002EP1245562A1 5-THIA-$g(v)-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
10/02/2002EP1244793A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244784A2 Methods and compositions for inhibiting neoplastic cell growth
10/02/2002EP1244781A2 Antisense oligonucleotides
10/02/2002EP1244708A1 Method for treating inflammation
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244685A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244672A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
1 ... 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 ... 878